Officinae Bio

📍 Venice, Italy🗓 Founded 2020👥 17 employees💰 Last funded Apr 2022
Biotechnology Research🌐 officinae.bio
Website LinkedIn
At Officinae Bio were developing a platform to support the future of biologically designed therapeutics. By developing breakthroughs in AI-enabled methodologies for nucleic manufacture we’re supporting pioneering research in Gene-modified Cell therapy, Gene therapy and RNA therapeutic research. DNA platform An automated platform for streamlined development of plasmids and libraries for viral vector and mRNA. RNA platform Our industry leading mRNA development and manufacturing solutions support rapid turnaround, advanced transcription capabilities and precision control over regulatory sequences design.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Officinae Bio?
Officinae Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Officinae Bio last raise funding?
The most recent investment in Officinae Bio recorded on gritt.io was in April 2022.
When was Officinae Bio founded?
Officinae Bio was founded in 2020.
What industry is Officinae Bio in?
Officinae Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Officinae Bio based?
Officinae Bio is headquartered in Venice, Italy.